The antigenic competition that occurs when pilus antigens of different
serogroups are combined in multivalent vaccines for foot rot has been
investigated using recombinant pilus antigens. Our prototype vaccine
contains pill from nine serogroups of Dichelobacter nodosus which are
expressed in Pseudomonas aeruginosa. Sheep inoculated with this multiv
alent vaccine were not as well protected against foot rot as those giv
en the monovalent vaccine. Levels of agglutinating and total antibody
specific far any particular pill serogroup were found to be significan
tly reduced in sheep vaccinated with six or more closely related pill.
This effect was more pronounced for agglutinating antibody, which is
thought to mediate protection, but was also observed with total antibo
dy levels measured by ELISA. The antigenic competition was not associa
ted with the total antigen load as a tenfold higher dose of monovalent
pill induced high titres of antibody. Furthermore, distributing the v
accine to four sites, each draining to a different lymph node, failed
to overcome the competition. Experiments with mixtures of monospecific
sera indicate that the phenomenon is unlikely to be due to blocking o
f serogroup-specific protective antibodies by an excess of cross-react
ive non-protective antibody elicited by heterologous pili.